The Conference is Now Open!
The 2020 Cholangiocarcinoma Foundation Annual Conference.
Our online conference format will allow patients, caregivers, scientists, researchers, and healthcare providers from around the globe to convene without traveling to Salt Lake City. The event will continue to be the premier source for the presentation of cutting-edge research, innovative therapies, and patient education in the field of cholangiocarcinoma.
Registration is required. If you previously registered for the conference, you will need to re-register to access our new platform.
Your registration will give you access to conference materials and recordings as well as raffle tickets. The first 500 patients/caregivers registered (one per household) will receive a goodie bag packed with fun swag.
Thanks to the generosity of our sponsors, we are able to make this virtual conference and its recordings free for registered participants.
2020 Conference by the Numbers
July 22-24, 2020
Jesús M Banales, PhD
San Sebastián, Spain
Rachna T Shroff, MD, MS
University of Arizona Cancer Center
Tucson, Arizona, USA
2020 Cholangiocarcinoma Foundation Annual Conference
The 2020 Conference will build upon the foundation laid at this year\'s meeting as key opinion leaders both nationally and internationally, come together to collaborate and exchange knowledge. The program will seek to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma by:
Increasing the knowledge and understanding of attendees about key issues central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma
A New Perspective
Identifying gaps and gathering consensus on rapidly changing advances in basic, translational, and clinical research
Stimulating interdisciplinary cross-cooperation and sharing best practices by developing, strengthening, and supporting collaborations
Fostering dialogue and inspiring innovation across the world
Further, because patients living with cholangiocarcinoma have a direct stake in their own medical care and are in a unique position to provide input, CCF has expanded its Annual Conference to include programming that addresses questions and concerns that are important to patients and their families. Patients and caregivers-having experienced the disease firsthand-will be invited to learn about cholangiocarcinoma, share their personal experiences, and contribute to future efforts to further cholangiocarcinoma research.
Who Should Attend?
Who Should Attend?
- Nurses specializing in oncology, intensive care, and palliative care
- Pharmaceutical Companies
- Government Regulators
- Patients, Caregivers and others invested in the field of cholangiocarcinoma